Co-design of an enhanced consumer engagement process

18 March 2024 - A consumer-led Co-design Working Group has developed proposed recommendations for enhancing consumer engagement processes to enable ...

Read more →

Together for high standards in the assessment of health technologies in Europe from 2025

1 March 2024 - A few months before the EU HTA regulation came into force, a delegation from the French HTA ...

Read more →

FDA and EMA launch parallel scientific advice pilot program for complex generics

7 February 2024 - CDER’s Office of Generic Drugs and the EMA launched a voluntary pilot program to facilitate concurrent discussions ...

Read more →

Updates on NICE and SMC collaboration on MTA for cystic fibrosis

1 February 2024 - On 19 December 2023, we advised that NICE would be liaising with key stakeholders to determine ...

Read more →

PHARMAC joins global health technology assessment network

25 January 2024 - PHARMAC has joined the International Network of Agencies for Health Technology Assessment (INAHTA) - a network ...

Read more →

MHRA’s new international recognition procedure goes live from 1 January 2024

2 January 2024 - In partnership with other global regulators, the international recognition procedure is expected to further help bring life-saving ...

Read more →

MHRA joins global regulatory partners in celebrating ten years of international medicines regulatory cooperation

9 November 2023 - As a founding member and former chair of the International Coalition of Medicines Regulatory Authorities (ICMRA), the MHRA ...

Read more →

FDA notes “continued growth” of Orbis collaborative review program, adds EMA as observer

1 November 2023 - There has been “continued growth” in the number of applications submitted to Project Orbis, and the ...

Read more →

Ethical and legal considerations in social media research for health technology assessment: conclusions from a scoping review

20 October 2023 - The objective was to identify and describe the published guidance and current academic discourse of ethical issues ...

Read more →

International HTA collaboration expands

20 September 2023 - The international collaboration between six health technology assessment bodies from across the UK, Australia and Canada ...

Read more →

MHRA’s new International Recognition Procedure: how does it shape up?

12 September 2023 - The field of life sciences and medicine development has become increasingly global. Multinational firms must make informed ...

Read more →

International heath technology assessment collaboration expands

24 August 2023 - The international collaboration between six health technology assessment bodies from across the UK, Australia and Canada has ...

Read more →

Patient and citizen participation at the organisational level in health technology assessment: an exploratory study in five jurisdictions

8 August 2023 - While patient participation in individual health technology assessments has been frequently described in the literature, patient and ...

Read more →

CDER collaborates with global regulators on pharmaceutical quality assessments and inspections

28 July 2023 - The FDA and the EMA recently completed the first collaborative assessment of a proposed post-approval change ...

Read more →

PHARMAC joins international collaboration to advance use of health technology assessments

20 July 2023 - PHARMAC has joined an international collaboration of government health technology assessment agencies.  ...

Read more →